 |
|
Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France
Grégoire Mercier, David Pau, Guillaume Bourel, Manon Belhassen, Floriane Deygas, Clarisse Marchal, Sophie Larrieu, Alexandre Civet, Xavier Moisset
J Mult Scler Neuroimmunol. 2025;16(1):19-25. Published online 2025 Jun 30 DOI: https://doi.org/10.59578/jmsni.2025.16.1.19-25
|
|
Citations to this article as recorded by
 A clustering-based approach to characterize autonomy profiles among multiple sclerosis patients: an application of the Qluster method in the FOCAL-MS2 study
David PAU, Alexandre Civet, Cécile Donzé, Géraud Paillot, Claude Mekies, Mikael Cohen, Lucie Brechenmacher, Catherine Mouzawak, Patrick Vermersch, Cyril Esnault, Svetlana Le Ralle
Journal of Patient-Reported Outcomes.2026;[Epub] CrossRef
|